Biopharma Business

Tag "Brain Cancer"

EMA Recommends Approval of New Treatment for Brain Cancer

Apeiron Biologics has announced that the EMA’s CHMP has recommended the approval of APN311 for immunotherapy of high risk neuroblastoma. Apeiron Biologics is a Vienna-based biotech company developing immunological approaches

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here